Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer.
Through our long-standing mastery of technical and regulatory consultation services, LCS serves all areas of FDA-related activities for the Pharma, Biotech, Biologics, Diagnostic, Device & Allied Health Industries. We serve a diverse base of loyal clients worldwide, from emerging-to-enterprise organizations.
Flex is the manufacturing partner of choice that helps a diverse customer base design and build products that improve the world. Through the collective strength of a global workforce across 30 countries and responsible, sustainable operations, Flex delivers technology innovation, supply chain, and manufacturing solutions to diverse industries and end markets. Flex’s health solutions business focuses on medical device and drug delivery design, development and manufacturing solutions for pharmaceutical and medtech companies. Our approach is supported by FDA-registered and ISO 13485 compliant and ISO 11608-1 accredited facilities, with a world-class single quality system across sites. For more information, visit www.flex.com
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.eu and connect on Twitter and Facebook.
atrify is the leading provider for product content solutions that enables more than 20,000 users in over 50 countries to share accurate and reliable content with UDI regulatory bodies (e.g. EUDAMED or GUDID) as well as their commercial trading partners and end-users such as doctors, nurses or patients. With dedicated expert services, atrify provides a holistic solution portfolio for transparency, regulatory compliance, and cross-channel trading.
Werfen is a growing, privately held corporation that was founded in 1966 in Barcelona, Spain.
We are a worldwide leader in in vitro diagnostics (IVD) in the specialties of Hemostasis, Acute Care Diagnostics and Autoimmunity.
At present, we operate directly in nearly 30 countries and in more than 100 territories through distributors. Our R&D and production centers are located in the United States and Europe.
